HOPO-101 next-generation oral chelator for gadolinium — higher binding affinity than DTPA, less mineral depletion, currently in clinical trials by HOPO Therapeutics.
2 resources available
Next-generation oral chelator background, clinical trial context, and comparison with DTPA for gadolinium removal.
DTPA chelation protocols for gadolinium removal, what to expect, and finding providers.